marketcap
Facebook
Twitter
Telegram
Report an ErrorDicerna Pharmaceuticals, Inc. Financial Ratios 2011-2024 | DRNA
Annual Financial Ratios Dicerna Pharmaceuticals, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-14.9 | -11.1 | -6.3 | -3.5 | -0.9 | -2.1 | -7.1 | -41.3 | - | - |
P/S |
10.2 | 55.7 | 90.5 | 92.6 | 182.6 | 724.5 | - | - | - | - |
EV/EBITDA |
-14.4 | -9.3 | -8.3 | -2.4 | -0.6 | -1.2 | -7.2 | -42.6 | - | - |
PEG |
-1.09 | 1.11 | -0.11 | 0.13 | -0.13 | 0.71 | 0.05 | -0.55 | - | - |
P/B |
12.2 | 8.7 | 2.8 | 2.1 | 1.3 | 1.5 | 3.5 | -11.1 | - | - |
P/CF |
10.3 | -189.1 | 31.2 | -4.6 | -1.1 | -2.7 | -9.3 | -67.3 | - | - |
ROE % |
-81.85 | -79.15 | -44.27 | -59.31 | -144.42 | -69.04 | -48.75 | 26.87 | - | - |
ROA % |
-15.93 | -20.16 | -21.72 | -49.67 | -116.12 | -62.82 | -46.27 | -37.19 | - | - |
ROCE % |
-21.36 | -36.04 | -19.44 | -58.12 | -144.99 | -69.24 | -45.81 | -41.26 | - | - |
DSO |
80.1 | 3085.7 | 5958.1 | 383.4 | 707.7 | 105.1 | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - |
All numbers in USD currency